Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $35.67 in the prior trading day, Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $35.40, down -0.76%. In other words, the price has decreased by -$0.76 from its previous closing price. On the day, 0.36 million shares were traded. ZLAB stock price reached its highest trading level at $36.03 during the session, while it also had its lowest trading level at $35.02.
Ratios:
Our goal is to gain a better understanding of ZLAB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $55.
On March 03, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $29 to $36.10.
On December 14, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $47.50.Morgan Stanley initiated its Overweight rating on December 14, 2023, with a $47.50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 17 ’25 when Amado Rafael sold 3,000 shares for $38.41 per share. The transaction valued at 115,230 led to the insider holds 30,834 shares of the business.
Amado Rafael bought 3,000 shares of ZLAB for $115,230 on Mar 17 ’25. On Mar 05 ’25, another insider, Du Ying, who serves as the Officer of the company, bought 46,389 shares for $35.55 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 3832970496 and an Enterprise Value of 37458792448. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.68 while its Price-to-Book (P/B) ratio in mrq is 4.54. Its current Enterprise Value per Revenue stands at 93.885 whereas that against EBITDA is -138.602.
Stock Price History:
The Beta on a monthly basis for ZLAB is 1.13, which has changed by 1.1865349 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $39.61, while it has fallen to a 52-week low of $13.48. The 50-Day Moving Average of the stock is 14.10%, while the 200-Day Moving Average is calculated to be 41.88%.
Shares Statistics:
The stock has traded on average 843.13K shares per day over the past 3-months and 677240 shares per day over the last 10 days, according to various share statistics. A total of 109.14M shares are outstanding, with a floating share count of 108.11M. Insiders hold about 0.94% of the company’s shares, while institutions hold 51.11% stake in the company. Shares short for ZLAB as of 1740700800 were 7828888 with a Short Ratio of 9.29, compared to 1738281600 on 7714353. Therefore, it implies a Short% of Shares Outstanding of 7828888 and a Short% of Float of 8.229999000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Zai Lab Limited ADR (ZLAB) is currently being evaluated by 3.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.4 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.32 and -$2.1 for the fiscal current year, implying an average EPS of -$1.61. EPS for the following year is $0.67, with 8.0 analysts recommending between $5.37 and -$0.97.
Revenue Estimates
4 analysts predict $118.39M in revenue for the current quarter. It ranges from a high estimate of $121.92M to a low estimate of $116.4M. As of the current estimate, Zai Lab Limited ADR’s year-ago sales were $87.15MFor the next quarter, 4 analysts are estimating revenue of $130.47M. There is a high estimate of $133.9M for the next quarter, whereas the lowest estimate is $128.5M.
A total of 13 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $582.1M, while the lowest revenue estimate was $551M, resulting in an average revenue estimate of $564.72M. In the same quarter a year ago, actual revenue was $398.99MBased on 13 analysts’ estimates, the company’s revenue will be $833.29M in the next fiscal year. The high estimate is $920M and the low estimate is $715M.
